Global PD-L1 and PIK3CA Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 268287
  • calendar_today Published On: Jan, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The PD-L1 and PIK3CA Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global PD-L1 and PIK3CA Testing market size is estimated to be worth US$ 536.9 million in 2021 and is forecast to a readjusted size of USD 1892 million by 2028 with a CAGR of 19.7% during review period. Hospital accounting for % of the PD-L1 and PIK3CA Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While PD-L1 Testing segment is altered to a % CAGR between 2022 and 2028.

Global key companies of PD-L1 and PIK3CA Testing include Agilent Technologies, Roche, QIAGEN, EntroGen, and Amoy Diagnostics, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

PD-L1 and PIK3CA Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

PD-L1 Testing

PIK3CA Testing

Market segment by Application, can be divided into

Hospital

Diagnostic Center

Others

Market segment by players, this report covers

Agilent Technologies

Roche

QIAGEN

EntroGen

Amoy Diagnostics

ACCB Biotech

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe PD-L1 and PIK3CA Testing product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of PD-L1 and PIK3CA Testing, with revenue, gross margin and global market share of PD-L1 and PIK3CA Testing from 2019 to 2022.

Chapter 3, the PD-L1 and PIK3CA Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and PD-L1 and PIK3CA Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe PD-L1 and PIK3CA Testing research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of PD-L1 and PIK3CA Testing

1.2 Classification of PD-L1 and PIK3CA Testing by Type

1.2.1 Overview: Global PD-L1 and PIK3CA Testing Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global PD-L1 and PIK3CA Testing Revenue Market Share by Type in 2021

1.2.3 PD-L1 Testing

1.2.4 PIK3CA Testing

1.3 Global PD-L1 and PIK3CA Testing Market by Application

1.3.1 Overview: Global PD-L1 and PIK3CA Testing Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospital

1.3.3 Diagnostic Center

1.3.4 Others

1.4 Global PD-L1 and PIK3CA Testing Market Size & Forecast

1.5 Global PD-L1 and PIK3CA Testing Market Size and Forecast by Region

1.5.1 Global PD-L1 and PIK3CA Testing Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global PD-L1 and PIK3CA Testing Market Size by Region, (2017-2022)

1.5.3 North America PD-L1 and PIK3CA Testing Market Size and Prospect (2017-2028)

1.5.4 Europe PD-L1 and PIK3CA Testing Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific PD-L1 and PIK3CA Testing Market Size and Prospect (2017-2028)

1.5.6 South America PD-L1 and PIK3CA Testing Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa PD-L1 and PIK3CA Testing Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 PD-L1 and PIK3CA Testing Market Drivers

1.6.2 PD-L1 and PIK3CA Testing Market Restraints

1.6.3 PD-L1 and PIK3CA Testing Trends Analysis

2 Company Profiles

2.1 Agilent Technologies

2.1.1 Agilent Technologies Details

2.1.2 Agilent Technologies Major Business

2.1.3 Agilent Technologies PD-L1 and PIK3CA Testing Product and Solutions

2.1.4 Agilent Technologies PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Agilent Technologies Recent Developments and Future Plans

2.2 Roche

2.2.1 Roche Details

2.2.2 Roche Major Business

2.2.3 Roche PD-L1 and PIK3CA Testing Product and Solutions

2.2.4 Roche PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Roche Recent Developments and Future Plans

2.3 QIAGEN

2.3.1 QIAGEN Details

2.3.2 QIAGEN Major Business

2.3.3 QIAGEN PD-L1 and PIK3CA Testing Product and Solutions

2.3.4 QIAGEN PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 QIAGEN Recent Developments and Future Plans

2.4 EntroGen

2.4.1 EntroGen Details

2.4.2 EntroGen Major Business

2.4.3 EntroGen PD-L1 and PIK3CA Testing Product and Solutions

2.4.4 EntroGen PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 EntroGen Recent Developments and Future Plans

2.5 Amoy Diagnostics

2.5.1 Amoy Diagnostics Details

2.5.2 Amoy Diagnostics Major Business

2.5.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Product and Solutions

2.5.4 Amoy Diagnostics PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Amoy Diagnostics Recent Developments and Future Plans

2.6 ACCB Biotech

2.6.1 ACCB Biotech Details

2.6.2 ACCB Biotech Major Business

2.6.3 ACCB Biotech PD-L1 and PIK3CA Testing Product and Solutions

2.6.4 ACCB Biotech PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 ACCB Biotech Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global PD-L1 and PIK3CA Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 PD-L1 and PIK3CA Testing Players Market Share in 2021

3.2.2 Top 10 PD-L1 and PIK3CA Testing Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 PD-L1 and PIK3CA Testing Players Head Office, Products and Services Provided

3.4 PD-L1 and PIK3CA Testing Mergers & Acquisitions

3.5 PD-L1 and PIK3CA Testing New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global PD-L1 and PIK3CA Testing Revenue and Market Share by Type (2017-2022)

4.2 Global PD-L1 and PIK3CA Testing Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global PD-L1 and PIK3CA Testing Revenue Market Share by Application (2017-2022)

5.2 Global PD-L1 and PIK3CA Testing Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America PD-L1 and PIK3CA Testing Revenue by Type (2017-2028)

6.2 North America PD-L1 and PIK3CA Testing Revenue by Application (2017-2028)

6.3 North America PD-L1 and PIK3CA Testing Market Size by Country

6.3.1 North America PD-L1 and PIK3CA Testing Revenue by Country (2017-2028)

6.3.2 United States PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

6.3.3 Canada PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

6.3.4 Mexico PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe PD-L1 and PIK3CA Testing Revenue by Type (2017-2028)

7.2 Europe PD-L1 and PIK3CA Testing Revenue by Application (2017-2028)

7.3 Europe PD-L1 and PIK3CA Testing Market Size by Country

7.3.1 Europe PD-L1 and PIK3CA Testing Revenue by Country (2017-2028)

7.3.2 Germany PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

7.3.3 France PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

7.3.4 United Kingdom PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

7.3.5 Russia PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

7.3.6 Italy PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific PD-L1 and PIK3CA Testing Revenue by Type (2017-2028)

8.2 Asia-Pacific PD-L1 and PIK3CA Testing Revenue by Application (2017-2028)

8.3 Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region

8.3.1 Asia-Pacific PD-L1 and PIK3CA Testing Revenue by Region (2017-2028)

8.3.2 China PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

8.3.3 Japan PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

8.3.4 South Korea PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

8.3.5 India PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

8.3.7 Australia PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America PD-L1 and PIK3CA Testing Revenue by Type (2017-2028)

9.2 South America PD-L1 and PIK3CA Testing Revenue by Application (2017-2028)

9.3 South America PD-L1 and PIK3CA Testing Market Size by Country

9.3.1 South America PD-L1 and PIK3CA Testing Revenue by Country (2017-2028)

9.3.2 Brazil PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

9.3.3 Argentina PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa PD-L1 and PIK3CA Testing Revenue by Type (2017-2028)

10.2 Middle East & Africa PD-L1 and PIK3CA Testing Revenue by Application (2017-2028)

10.3 Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country

10.3.1 Middle East & Africa PD-L1 and PIK3CA Testing Revenue by Country (2017-2028)

10.3.2 Turkey PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

10.3.4 UAE PD-L1 and PIK3CA Testing Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global PD-L1 and PIK3CA Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global PD-L1 and PIK3CA Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market PD-L1 and PIK3CA Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global PD-L1 and PIK3CA Testing Revenue (USD Million) by Region (2017-2022)

Table 5. Global PD-L1 and PIK3CA Testing Revenue Market Share by Region (2023-2028)

Table 6. Agilent Technologies Corporate Information, Head Office, and Major Competitors

Table 7. Agilent Technologies Major Business

Table 8. Agilent Technologies PD-L1 and PIK3CA Testing Product and Solutions

Table 9. Agilent Technologies PD-L1 and PIK3CA Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Roche Corporate Information, Head Office, and Major Competitors

Table 11. Roche Major Business

Table 12. Roche PD-L1 and PIK3CA Testing Product and Solutions

Table 13. Roche PD-L1 and PIK3CA Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. QIAGEN Corporate Information, Head Office, and Major Competitors

Table 15. QIAGEN Major Business

Table 16. QIAGEN PD-L1 and PIK3CA Testing Product and Solutions

Table 17. QIAGEN PD-L1 and PIK3CA Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. EntroGen Corporate Information, Head Office, and Major Competitors

Table 19. EntroGen Major Business

Table 20. EntroGen PD-L1 and PIK3CA Testing Product and Solutions

Table 21. EntroGen PD-L1 and PIK3CA Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Amoy Diagnostics Corporate Information, Head Office, and Major Competitors

Table 23. Amoy Diagnostics Major Business

Table 24. Amoy Diagnostics PD-L1 and PIK3CA Testing Product and Solutions

Table 25. Amoy Diagnostics PD-L1 and PIK3CA Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. ACCB Biotech Corporate Information, Head Office, and Major Competitors

Table 27. ACCB Biotech Major Business

Table 28. ACCB Biotech PD-L1 and PIK3CA Testing Product and Solutions

Table 29. ACCB Biotech PD-L1 and PIK3CA Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Global PD-L1 and PIK3CA Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 31. Global PD-L1 and PIK3CA Testing Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 32. Breakdown of PD-L1 and PIK3CA Testing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 33. PD-L1 and PIK3CA Testing Players Head Office, Products and Services Provided

Table 34. PD-L1 and PIK3CA Testing Mergers & Acquisitions in the Past Five Years

Table 35. PD-L1 and PIK3CA Testing New Entrants and Expansion Plans

Table 36. Global PD-L1 and PIK3CA Testing Revenue (USD Million) by Type (2017-2022)

Table 37. Global PD-L1 and PIK3CA Testing Revenue Share by Type (2017-2022)

Table 38. Global PD-L1 and PIK3CA Testing Revenue Forecast by Type (2023-2028)

Table 39. Global PD-L1 and PIK3CA Testing Revenue by Application (2017-2022)

Table 40. Global PD-L1 and PIK3CA Testing Revenue Forecast by Application (2023-2028)

Table 41. North America PD-L1 and PIK3CA Testing Revenue by Type (2017-2022) & (USD Million)

Table 42. North America PD-L1 and PIK3CA Testing Revenue by Type (2023-2028) & (USD Million)

Table 43. North America PD-L1 and PIK3CA Testing Revenue by Application (2017-2022) & (USD Million)

Table 44. North America PD-L1 and PIK3CA Testing Revenue by Application (2023-2028) & (USD Million)

Table 45. North America PD-L1 and PIK3CA Testing Revenue by Country (2017-2022) & (USD Million)

Table 46. North America PD-L1 and PIK3CA Testing Revenue by Country (2023-2028) & (USD Million)

Table 47. Europe PD-L1 and PIK3CA Testing Revenue by Type (2017-2022) & (USD Million)

Table 48. Europe PD-L1 and PIK3CA Testing Revenue by Type (2023-2028) & (USD Million)

Table 49. Europe PD-L1 and PIK3CA Testing Revenue by Application (2017-2022) & (USD Million)

Table 50. Europe PD-L1 and PIK3CA Testing Revenue by Application (2023-2028) & (USD Million)

Table 51. Europe PD-L1 and PIK3CA Testing Revenue by Country (2017-2022) & (USD Million)

Table 52. Europe PD-L1 and PIK3CA Testing Revenue by Country (2023-2028) & (USD Million)

Table 53. Asia-Pacific PD-L1 and PIK3CA Testing Revenue by Type (2017-2022) & (USD Million)

Table 54. Asia-Pacific PD-L1 and PIK3CA Testing Revenue by Type (2023-2028) & (USD Million)

Table 55. Asia-Pacific PD-L1 and PIK3CA Testing Revenue by Application (2017-2022) & (USD Million)

Table 56. Asia-Pacific PD-L1 and PIK3CA Testing Revenue by Application (2023-2028) & (USD Million)

Table 57. Asia-Pacific PD-L1 and PIK3CA Testing Revenue by Region (2017-2022) & (USD Million)

Table 58. Asia-Pacific PD-L1 and PIK3CA Testing Revenue by Region (2023-2028) & (USD Million)

Table 59. South America PD-L1 and PIK3CA Testing Revenue by Type (2017-2022) & (USD Million)

Table 60. South America PD-L1 and PIK3CA Testing Revenue by Type (2023-2028) & (USD Million)

Table 61. South America PD-L1 and PIK3CA Testing Revenue by Application (2017-2022) & (USD Million)

Table 62. South America PD-L1 and PIK3CA Testing Revenue by Application (2023-2028) & (USD Million)

Table 63. South America PD-L1 and PIK3CA Testing Revenue by Country (2017-2022) & (USD Million)

Table 64. South America PD-L1 and PIK3CA Testing Revenue by Country (2023-2028) & (USD Million)

Table 65. Middle East & Africa PD-L1 and PIK3CA Testing Revenue by Type (2017-2022) & (USD Million)

Table 66. Middle East & Africa PD-L1 and PIK3CA Testing Revenue by Type (2023-2028) & (USD Million)

Table 67. Middle East & Africa PD-L1 and PIK3CA Testing Revenue by Application (2017-2022) & (USD Million)

Table 68. Middle East & Africa PD-L1 and PIK3CA Testing Revenue by Application (2023-2028) & (USD Million)

Table 69. Middle East & Africa PD-L1 and PIK3CA Testing Revenue by Country (2017-2022) & (USD Million)

Table 70. Middle East & Africa PD-L1 and PIK3CA Testing Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. PD-L1 and PIK3CA Testing Picture

Figure 2. Global PD-L1 and PIK3CA Testing Revenue Market Share by Type in 2021

Figure 3. PD-L1 Testing

Figure 4. PIK3CA Testing

Figure 5. PD-L1 and PIK3CA Testing Revenue Market Share by Application in 2021

Figure 6. Hospital Picture

Figure 7. Diagnostic Center Picture

Figure 8. Others Picture

Figure 9. Global PD-L1 and PIK3CA Testing Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global PD-L1 and PIK3CA Testing Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global PD-L1 and PIK3CA Testing Revenue Market Share by Region (2017-2028)

Figure 12. Global PD-L1 and PIK3CA Testing Revenue Market Share by Region in 2021

Figure 13. North America PD-L1 and PIK3CA Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe PD-L1 and PIK3CA Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific PD-L1 and PIK3CA Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America PD-L1 and PIK3CA Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa PD-L1 and PIK3CA Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. PD-L1 and PIK3CA Testing Market Drivers

Figure 19. PD-L1 and PIK3CA Testing Market Restraints

Figure 20. PD-L1 and PIK3CA Testing Market Trends

Figure 21. Agilent Technologies Recent Developments and Future Plans

Figure 22. Roche Recent Developments and Future Plans

Figure 23. QIAGEN Recent Developments and Future Plans

Figure 24. EntroGen Recent Developments and Future Plans

Figure 25. Amoy Diagnostics Recent Developments and Future Plans

Figure 26. ACCB Biotech Recent Developments and Future Plans

Figure 27. Global PD-L1 and PIK3CA Testing Revenue Share by Players in 2021

Figure 28. PD-L1 and PIK3CA Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 29. Global Top 3 Players PD-L1 and PIK3CA Testing Revenue Market Share in 2021

Figure 30. Global Top 10 Players PD-L1 and PIK3CA Testing Revenue Market Share in 2021

Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 32. Global PD-L1 and PIK3CA Testing Revenue Share by Type in 2021

Figure 33. Global PD-L1 and PIK3CA Testing Market Share Forecast by Type (2023-2028)

Figure 34. Global PD-L1 and PIK3CA Testing Revenue Share by Application in 2021

Figure 35. Global PD-L1 and PIK3CA Testing Market Share Forecast by Application (2023-2028)

Figure 36. North America PD-L1 and PIK3CA Testing Sales Market Share by Type (2017-2028)

Figure 37. North America PD-L1 and PIK3CA Testing Sales Market Share by Application (2017-2028)

Figure 38. North America PD-L1 and PIK3CA Testing Revenue Market Share by Country (2017-2028)

Figure 39. United States PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 40. Canada PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 41. Mexico PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Europe PD-L1 and PIK3CA Testing Sales Market Share by Type (2017-2028)

Figure 43. Europe PD-L1 and PIK3CA Testing Sales Market Share by Application (2017-2028)

Figure 44. Europe PD-L1 and PIK3CA Testing Revenue Market Share by Country (2017-2028)

Figure 45. Germany PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. France PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. United Kingdom PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Russia PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Italy PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Asia-Pacific PD-L1 and PIK3CA Testing Sales Market Share by Type (2017-2028)

Figure 51. Asia-Pacific PD-L1 and PIK3CA Testing Sales Market Share by Application (2017-2028)

Figure 52. Asia-Pacific PD-L1 and PIK3CA Testing Revenue Market Share by Region (2017-2028)

Figure 53. China PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Japan PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. South Korea PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. India PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Southeast Asia PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Australia PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. South America PD-L1 and PIK3CA Testing Sales Market Share by Type (2017-2028)

Figure 60. South America PD-L1 and PIK3CA Testing Sales Market Share by Application (2017-2028)

Figure 61. South America PD-L1 and PIK3CA Testing Revenue Market Share by Country (2017-2028)

Figure 62. Brazil PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Argentina PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Middle East and Africa PD-L1 and PIK3CA Testing Sales Market Share by Type (2017-2028)

Figure 65. Middle East and Africa PD-L1 and PIK3CA Testing Sales Market Share by Application (2017-2028)

Figure 66. Middle East and Africa PD-L1 and PIK3CA Testing Revenue Market Share by Country (2017-2028)

Figure 67. Turkey PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Saudi Arabia PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. UAE PD-L1 and PIK3CA Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Methodology

Figure 71. Research Process and Data Source